Personalized Medication Delivery and Management System
Legal Citation
Summary of the Inventive Concept
A next-generation medication delivery system that integrates AI, wearable technology, and blockchain to optimize medication adherence, efficacy, and safety.
Background and Problem Solved
The original patent relates to a medication delivery device with a sensed element used in dose detection. However, it has limitations in terms of user experience, data analysis, and security. The present inventive concept addresses these limitations by introducing a personalized medication delivery and management system that leverages advanced technologies to improve patient outcomes.
Detailed Description of the Inventive Concept
The system comprises a self-learning AI module that adapts to a user's injection habits and optimizes dose detection based on machine learning algorithms. A wearable device tracks injection events and communicates with a cloud-based analytics platform to provide personalized feedback and alerts. The system also integrates a neural network that predicts medication efficacy using data from the medication delivery device, electronic health records, and genomic profiles. Furthermore, the system includes a medication delivery device with an integrated biosensor that detects biomarkers in real-time, enabling personalized dosing and treatment optimization. The cloud-based platform utilizes blockchain technology to ensure secure and transparent data exchange between patients, healthcare providers, and pharmaceutical companies.
Novelty and Inventive Step
The new claims introduce a paradigm shift in medication delivery and management by integrating AI, wearable technology, and blockchain. The self-learning AI module, wearable device, and cloud-based analytics platform are novel and non-obvious compared to the original patent. The use of blockchain technology for secure data exchange is also a new and inventive step.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include different AI algorithms, wearable device designs, and blockchain protocols. Variations could also include integration with other healthcare systems, such as electronic health records or telemedicine platforms.
Potential Commercial Applications and Market
The personalized medication delivery and management system has significant commercial potential in the pharmaceutical, healthcare, and technology industries. The system could be marketed to pharmaceutical companies, healthcare providers, and patients, offering improved medication adherence, efficacy, and safety.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically medication delivery systems and injection technologies, with expertise in sensor integration, dose detection, and electronic health monitoring
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, 3-5 years experience in medical device development, familiar with sensor technologies, data integration, and healthcare software platforms
Obviousness Rationale
A PHOSITA would recognize that the source patent's foundational medication delivery device provides a natural technological progression toward intelligent, data-driven healthcare solutions. The PTD's AI-enhanced, blockchain-integrated system represents predictable technological evolution by applying known software and sensor technologies to an existing medical device framework. The core mechanical principles of dose detection remain consistent, with added layers of digital intelligence that would be considered an obvious enhancement by a skilled practitioner.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,770 |
|---|---|
| Title | Medication delivery device with a sensed element |
| Assignee(s) | Eli Lilly and Company |